Computer-Assisted Evaluation of Patient Information Leaflets (PILs) for Chronic Kidney Disease Compared with Marketed PILs

Printed educational materials play an important part in the treatment of disease. The patient may use them as a reference at home or to enhance knowledge. The goal of this study was to use standard approaches, such as Baker Able Leaflet Design (BALD) and readability score, to the evaluation of patients' opinions on Patient Information Leaflets (PILs) for chronic kidney disease. Participate were enrolled randomly, and some were taken at a convenient time. The study spanned 1 year in a hospital in Assam, India. We compiled our Patient Information Leaflets (PILs) by referring to various sources of information and translating them into the Assamese language. With the help of the BALD assessment strategy and user rating, we compared our PILs with available PILs on the website and marketed them. The prepared leaflets scored above standard in BALD and readability evaluations, indicating that they are above the industry standard. since their average score was greater than 25, the layout and design. This shows that the issue is important from the patient's perspective, which may encourage them to read the PILs. Even though a larger percentage of Indian consumers cannot read or write English, many PILs are still written in the English language. Without considering the patient's reading levels and ensuring proper style and design, PILs may not be understood or used. Every company has to take this into account when creating leaflets and, at the absolute least, in some of the most important local languages in which PILs must be published.

Automated summary

Printed educational materials play an important role in disease treatment, providing patients with reference and knowledge enhancement. This study evaluated patients' opinions on Patient Information Leaflets (PILs) for chronic kidney disease using standard approaches like BALD and readability score. The results showed that the prepared leaflets scored above industry standard, indicating the importance of the issue from the patient's perspective.